Company Overview - Co-Diagnostics, Inc. is a molecular diagnostics company that develops, manufactures, and markets advanced diagnostic technologies designed to detect and analyze nucleic acid molecules (DNA or RNA) [6] - The company utilizes proprietary technology to create specific tests for its Co-Dx PCR at-home and point-of-care platform, as well as to identify genetic markers for applications beyond infectious disease [6] Upcoming Events - Co-Diagnostics will host a booth at the 17th Annual Next Generation Dx Summit, taking place both virtually and in-person at the Capital Hilton in Washington, D.C. from August 18-20, 2025 [1] - Attendees are encouraged to visit Booth 12 to learn about the Co-Dx Logix Smart® suite of clinical laboratory solutions and the upcoming Co-Dx PCR diagnostics platform, which includes tests for upper respiratory infections, tuberculosis, and HPV, expected to enter clinical evaluations in 2025 [3] Industry Context - The Next Generation Dx Summit serves as a platform for international thought leaders to network and discuss advancements in diagnostics and technology innovation, focusing on areas such as point-of-care testing, decentralized testing, infectious diseases, liquid biopsy, and companion diagnostics [2]